graphic element
UrSure logo New.png
  • Home

  • About Us

  • How It Works

  • Evidence

  • News

    • Press Releases
    • Recent News
    • Videos
  • Contact Us

  • More

    Use tab to navigate through the menu items.
    • Twitter
    • LinkedIn
    • YouTube

    Knowledge

    Development of the UrSure test

    1. Development and Validation of a Point of Care, Urine Assay
    2. Development and Clinical Use Case of a Urine Tenofovir Adherence Test
    3. Development of a POC Urine Tenofovir Test – A PrEP and ART Adherence Tool
    4. Tenofovir Stability in Urine at Various Temperatures 

    The need

    for objective adherence monitoring

    1. Challenges to PrEP use; perceptions of urine tenofovir adherence monitoring
    2. Identifying Barriers and Assessing the Utility of Tenofovir Urine Testing
    3. Associations Between Urine Tenofovir Levels and Pharmacy Measures

    UrSure tests are accurate

    1. UrSure Assay for TFV to Monitor Adherence in real time to TDF/FTC as PrEP
    Poster
    Paper
    2. Evaluating Urine With Dried Blood Spots to Assess Tenofovir Levels 

    UrSure tests have clinical impact

    1. Urine TFV Testing to Measure PrEP Adherence in a Real World Setting
    2. Delivery of TDF/FTC for PrEP to Prevent HIV Using a Urine Adherence Assay
    3. Case Study: Sustained High PrEP Adherence at Midland Medical Center
    4. Case Study: PrEP Adherence in a Hotspot Jurisdiction's Department of Health
    Want to stay up to date with UrSure? Join our newsletter!
    • Twitter
    • LinkedIn
    EMAIL icon white.png
    CONTACT

    ©  2020 by UrSure, Inc., a wholly-owned subsidiary of OraSure Technologies, Inc., all rights reserved.